HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794.

AbstractOBJECTIVES:
Temozolomide (TMZ) is one of the most commonly used clinical drugs for glioblastoma (GBM) treatment, but its drug sensitivity needs to be improved. Gamabufotalin (CS-6), the primary component of the traditional Chinese medicine "ChanSu," was shown to have strong anti-cancer activity. However, more efforts should be directed towards reducing its toxicity or effective treatment doses.
METHODS:
Target fishing experiment, Western blotting, PCR, confocal immunofluorescence and molecular cloning techniques were performed to search for possible downstream signalling pathways. In addition, GBM xenografts were used to further determine the potential molecular mechanisms of the synergistic effects of CS-6 and TMZ in vivo.
RESULTS:
Mechanistic research revealed a negative feedback loop between ATP1A3 and AQP4 through which CS-6 inhibited GBM growth and mediated the synergistic treatment effect of CS-6 and TMZ. In addition, by mutating potential amino acid residues of ATP1A3, which were predicted by modelling and docking to interact with CS-6, we demonstrated that abrogating hydrogen bonding of the amino acid Thr794 interferes with the activation of ATP1A3 by CS-6 and that the Thr794Ala mutation directly affects the synergistic treatment efficacy of CS-6 and TMZ.
CONCLUSIONS:
As the main potential target of CS-6, ATP1A3 activation critically depends on the hydrogen bonding of Thr794 with CS-6. The combination of CS-6 and TMZ could significantly reduce the therapeutic doses and promote the anti-cancer efficacy of CS-6/TMZ monotherapy.
AuthorsYu-Long Lan, Cheng Chen, Xun Wang, Jia-Cheng Lou, Jin-Shan Xing, Shuang Zou, Ji-Liang Hu, Wen Lyu, Bo Zhang
JournalCell proliferation (Cell Prolif) Vol. 53 Issue 1 Pg. e12732 (Jan 2020) ISSN: 1365-2184 [Electronic] England
PMID31746080 (Publication Type: Journal Article)
Copyright© 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.
Chemical References
  • AQP4 protein, human
  • ATP1A3 protein, human
  • Aquaporin 4
  • Bufanolides
  • Neoplasm Proteins
  • gamabufotalin
  • Sodium-Potassium-Exchanging ATPase
  • Temozolomide
Topics
  • Animals
  • Aquaporin 4 (genetics, metabolism)
  • Bufanolides (pharmacology)
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm (drug effects, genetics)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Glioblastoma (drug therapy, genetics, metabolism, pathology)
  • Humans
  • Mice
  • Neoplasm Proteins (biosynthesis, genetics)
  • Sodium-Potassium-Exchanging ATPase (biosynthesis, genetics)
  • Temozolomide (pharmacology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: